SAN DIEGO, California. - October 16, 2006 - SoluLinK, The Conjugation CompanyTM, announced the formation of a Scientific Advisory Board (SAB) to oversee the research, development, and commercialization of SoluLinK’s next generation of vertically integrated bioconjugation, detection, and immobilization products. SoluLink is pleased to have the expertise of these accomplished professionals on its SAB:
